"Abiomed is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has three additional offices, two in Germany in the cities of Berlin and Aachen, and another in Japan. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President.
For fiscal year 2017, Abiomed reported $445.3 million in revenue and reported diluted earnings per share was $1.17 for the year.
As of March 2019, Michael R. Minogue was Chairman, CEO & President of the company, while Dr. David M. Weber was the Chief Operating Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients". Earlier in the year, the company had increased its 2019 revenue guidance to approximately $780 million." - (Wikipedia (en) 27.11.2019)
)